Cargando…

Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel

BACKGROUND: The aim of this study was to evaluate the protein spots of excretory - secretory products of Fasciola hepatica using two dimension electrophoresis method in the presence and absence of triclabendazole drug which can be considered to detect the target protein of the drug. METHODS: F. hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	FARIDI, Ashkan, FARAHNAK, Ali, GOLMOHAMMADI, Taghi, ESHRAGHIAN, Mohammadreza, SHARIFI, Yosef, MOLAEI RAD, Mohammadbagher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2014
Materias:	Medical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386040/ https://www.ncbi.nlm.nih.gov/pubmed/25848386

Ejemplares similares

Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro
por: SHRIFI, Yosef, et al.
Publicado: (2014)

Protein Detection of Excretory-Secretory Products and Somatic Extracts from Fasciola hepatica and F. gigantica Using Two-Dimensional Electrophoresis
por: RASOULI, Afshin, et al.
Publicado: (2019)

Activity of Superoxide Dismutase (SOD) Enzyme in the Excretory-Secretory Products of Fasciola hepatica and F. gigantica Parasites
por: Farahnak, A, et al.
Publicado: (2013)

Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay
por: Robles-Pérez, David, et al.
Publicado: (2015)

Carbohydrate Detection and Lectin Isolation from Tegumental Tissue of Fasciola hepatica
por: Farahnak, A, et al.
Publicado: (2010)

Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands
por: Winkelhagen, Annemarie J.S., et al.
Publicado: (2012)

Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
por: Davis, Chelsea N., et al.
Publicado: (2020)

Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle()
por: Brockwell, Yvette M., et al.
Publicado: (2013)

Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics
por: Collett, Clare F., et al.
Publicado: (2020)

A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance
por: Beesley, Nicola J., et al.
Publicado: (2023)

Transcriptome assembly dataset of anthelmintic response in Fasciola hepatica
por: Miranda-Miranda, Estefan, et al.
Publicado: (2021)

The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica
por: Stuart, Rebekah B., et al.
Publicado: (2021)

Proteomic Analysis of Fasciola hepatica Excretory and Secretory Products Co-Immunoprecipitated Using Time Course Infection Sera
por: Lan, Zhuo, et al.
Publicado: (2021)

Differences in the antibody response to adult Fasciola hepatica excretory/secretory products in experimentally and naturally infected cattle and sheep
por: Walsh, Tessa R, et al.
Publicado: (2021)

Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales
por: Kamaludeen, Juriah, et al.
Publicado: (2019)

Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
por: Morales, Maria L., et al.
Publicado: (2021)

Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones
por: Hodgkinson, Jane E., et al.
Publicado: (2018)

The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations
por: Fernandez-Baca, Martha V., et al.
Publicado: (2022)

Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica
por: Khan, M. A. Hannan, et al.
Publicado: (2017)

A Comparison between the Effects of Albendazole and Mebendazole on the Enzymatic Activity of Excretory / Secretory Products of Echinococcus granulosus Protoscoleces in Vitro
por: ADNANI SADATI, Seyed Jafar, et al.
Publicado: (2016)

Effect of Fasciola gigantica excretory secretory antigen on rat hematological indices
por: Ganga, G., et al.
Publicado: (2006)

Fasciola hepatica Extracellular Vesicles isolated from excretory-secretory products using a gravity flow method modulate dendritic cell phenotype and activity
por: Murphy, Anna, et al.
Publicado: (2020)

Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
por: Chakroborty, Anand, et al.
Publicado: (2023)

High prevalence of fasciolosis and evaluation of the efficacy of anthelmintics against Fasciola hepatica in buffaloes in Guangxi, China
por: Zhang, Ji-Li, et al.
Publicado: (2019)

Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases
por: Hanna, Robert
Publicado: (2015)

Fasciola hepatica in UK horses
por: Howell, A. K., et al.
Publicado: (2019)

Single Amino Acid Polymorphisms in the Fasciola hepatica Carboxylesterase Type B Gene and Their Potential Role in Anthelmintic Resistance
por: Miranda-Miranda, Estefan, et al.
Publicado: (2023)

Activity Assay of Glutathione S-Transferase (GSTs) Enzyme as a Diagnostic Biomarker for Liver Hydatid Cyst in Vitro
por: MOATAMEDI POUR, Lila, et al.
Publicado: (2014)

Gastric Pseudotumor due to Fasciola hepatica
por: Calixto-Aguilar, Lesly, et al.
Publicado: (2019)

Genetic diversity of Fasciola hepatica in Austria
por: Husch, Christian, et al.
Publicado: (2020)

Inmunodiagnóstico de parasitosis por fasciola hepática
por: Alfaro López, Martha Alicia
Publicado: (1987)

ABC transporters of the liver fluke Fasciola hepatica
por: Kudlacek, Oliver, et al.
Publicado: (2012)

In silico prediction of secretory proteins of Opisthorchis viverrini, Clonorchis sinensis and Fasciola hepatica that target the host cell nucleus
por: Machicado, Claudia, et al.
Publicado: (2021)

Fasciola hepatica Gastrodermal Cells Selectively Release Extracellular Vesicles via a Novel Atypical Secretory Mechanism
por: Bennett, Adam P. S., et al.
Publicado: (2022)

The Diterpenoid 7-Keto-Sempervirol, Derived from Lycium chinense, Displays Anthelmintic Activity against both Schistosoma mansoni and Fasciola hepatica
por: Edwards, Jennifer, et al.
Publicado: (2015)

Dysregulation of hepatic microRNA expression in C57BL/6 mice affected by excretory-secretory products of Fasciola gigantica
por: Shi, Wei, et al.
Publicado: (2020)

Anthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica
por: Ullah, Rizwan, et al.
Publicado: (2017)

Complete mitochondrial genomes of the ‘intermediate form’ of Fasciola and Fasciola gigantica, and their comparison with F. hepatica
por: Liu, Guo-Hua, et al.
Publicado: (2014)

Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola Gigantica that cause the zoonosis Fasciolosis
por: Lalor, Richard, et al.
Publicado: (2021)

Effect of Fasciola hepatica proteins on the functioning of rat hepatocytes
por: Wesołowska, Agnieszka, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cdsv7du323f56l2f91ibfc6fq0